Consumer Staples
$AN1
Anagenics (ASX: $AN1) reports strong Bouf Haircare launch
Bouf Haircare exceeds sales expectations, generating impressive royalties for Anagenics. International expansion considered.
Jun 27, 2025 11:31 AM Stock Piper

Anagenics announces successful Bouf Haircare launch

Anagenics (ASX:AN1) has reported a successful launch of Bouf Haircare, developed by York Street Brands using Anagenics' proprietary technology. The brand has surpassed expectations with strong market momentum, highlighted by the sell-out of its Flouf Factor Growth Tonic. Bouf Haircare is expected to generate $2.3 million in initial sales, translating to a $230,000 royalty for Anagenics. The brand is on track for $9 million in sales within its first year.

Bouf Haircare's impact on Anagenics' growth

Anagenics Limited has announced that its Bouf Haircare brand, launched in partnership with York Street Brands, is performing exceptionally well, surpassing initial sales expectations. The brand is forecasted to generate $9 million in its first year, significantly exceeding the expected minimum royalty payments over a decade. The collaboration with York Street Brands showcases Anagenics' strategic use of its proprietary technology and licensing model. With the potential for international market expansion, Bouf Haircare's success is set to strengthen Anagenics' profitability and reinforce its position in the health, beauty, and wellness sectors. Anagenics remains committed to advancing its existing brands, including évolis, while exploring further growth opportunities.

Executive insights on Bouf Haircare's performance

The success of Bouf Haircare underscores the strength of Anagenics' licensing model and highlights the effective monetisation of its intellectual property portfolio. The collaboration with York Street Brands, known for building successful consumer brands like BOOST LAB and tbh Skincare, has proven successful in bringing innovative formulations to market at scale. The royalty stream from Bouf Haircare is expected to enhance Anagenics' profitability and could further scale with potential international expansion. Anagenics retains the rights to continue marketing and expanding its existing hair regrowth brands, including évolis, within its owned-brand portfolio.